Guarini Kathryn
Director at REGN
- Sold, on record
- $660k
- Dollars the filings state
- Form 4 sales
- 2
- Latest Sep 2, 2026
- Form 144 notices
- 2
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- REGNREGENERON PHARMACEUTICALS, INC.Director
Sales by reason
2
Routine
0
Plan not stated
0
No plan
0
Unusual
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 144 notice REGNNoticeAug 10, 2026 2026
Filed to sell 400 shares ($320k)
Guarini Kathryn, Board member
10b5-1 planFirst sale on recordFiling
- 2 Form 4 sale REGNRoutineAug 10, 2026 same day
Sold 400 shares at $800.00 ($320k)
Guarini Kathryn, Director
10b5-1 planSold 39.9% of holdings ($802k position)603 shares leftFirst sale on recordFollows a Form 144Filing
- 3 Form 144 notice REGNNoticeSep 2, 2026 +23 days
Filed to sell 400 shares ($340k)
Guarini Kathryn, Director
10b5-1 planFiling
- 4 Form 4 sale REGNRoutineSep 2, 2026 same day
Sold 400 shares at $850.00 ($340k)
Guarini Kathryn, Director
10b5-1 planSold 39.9% of holdings ($853k position)603 shares leftFollows a Form 144Filing
Every transaction
Loading transactions…
Sales and notices (4)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Sep 2, 2026 | Sep 3, 2026 | REGN | Director | Form 4 sale | 400 | $340k | 39.9% | Routine | SEC |
| Sep 2, 2026 | Sep 2, 2026 | REGN | Director | Form 144 notice | 400 | $340k | Notice | SEC | |
| Aug 10, 2026 | Aug 12, 2026 | REGN | Director | Form 4 sale | 400 | $320k | 39.9% | Routine | SEC |
| Aug 10, 2026 | Aug 10, 2026 | REGN | Board member | Form 144 notice | 400 | $320k | Notice | SEC |